Physician profile
John T Cecil
NPI 1821168154
$12,558.95
in general payments reported to CMS, 2019-2025
33 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,327 · 2020: $1,187 · 2021: $1,408 · 2022: $1,467 · 2023: $1,693 · 2024: $1,287 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,121 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,121.41 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $4,491.62 | 2019-2025 | Qelbree, Qelbree |
| Abbvie INC. | $1,695.43 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Corium, LLC | $1,377.23 | 2021-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,125.18 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $713.39 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Takeda Pharmaceuticals U.S.A., INC. | $671.73 | 2019-2022 | |
| Shire North American Group INC | $371.28 | 2019 | |
| Allergan, INC. | $303.75 | 2019-2020 | |
| Axsome Therapeutics, INC. | $265.44 | 2022-2025 | Auvelity |
| Ironshore Pharmaceuticals INC. | $210.84 | 2019-2023 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $202.89 | 2019-2020 | |
| Novo Nordisk INC | $169.84 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Tris Pharma INC | $142.39 | 2020-2025 | Dyanavel Xr |
| Lilly USA, LLC | $135.11 | 2020-2025 | Mounjaro, Zepbound |
| Alkermes, INC. | $100.86 | 2019-2024 | Lybalvi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $72.80 | 2023-2025 | Spravato |
| Collegium Pharmaceutical, INC. | $68.23 | 2025 | Jornay Pm |
| Lundbeck LLC | $65.23 | 2020-2025 | Rexulti |
| Pfizer INC. | $54.97 | 2022-2025 | |
| Neos Therapeutics, LP | $38.50 | 2019 | |
| Genentech USA, INC. | $36.84 | 2019-2020 | |
| Owp Pharmaceuticals, INC. | $32.50 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.59 | 2025 | |
| Zyla Life Sciences, INC. | $28.23 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.76 | 2022 | |
| Amgen INC. | $19.46 | 2025 | Prolia, Evenity |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.99 | 2025 | |
| Janssen Biotech, INC. | $18.56 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.05 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $17.95 | 2019 | |
| Exact Sciences Corporation | $17.09 | 2024 | Cologuard Collection Kit |
| Antares Pharma, INC. | $14.91 | 2021 | |
| Adlon Therapeutics L.P. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cecil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.